Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 481

1.

White matter abnormalities across the lifespan of schizophrenia: a harmonized multi-site diffusion MRI study.

Cetin-Karayumak S, Di Biase MA, Chunga N, Reid B, Somes N, Lyall AE, Kelly S, Solgun B, Pasternak O, Vangel M, Pearlson G, Tamminga C, Sweeney JA, Clementz B, Schretlen D, Viher PV, Stegmayer K, Walther S, Lee J, Crow T, James A, Voineskos A, Buchanan RW, Szeszko PR, Malhotra AK, Hegde R, McCarley R, Keshavan M, Shenton M, Rathi Y, Kubicki M.

Mol Psychiatry. 2019 Sep 11. doi: 10.1038/s41380-019-0509-y. [Epub ahead of print]

PMID:
31511636
2.

Common Data Elements for National Institute of Mental Health-Funded Translational Early Psychosis Research.

Öngür D, Carter CS, Gur RE, Perkins D, Sawa A, Seidman LJ, Tamminga C, Huggins W, Hamilton C.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jun 29. pii: S2451-9022(19)30174-0. doi: 10.1016/j.bpsc.2019.06.009. [Epub ahead of print] Review.

PMID:
31439493
3.

Characterizing functional regional homogeneity (ReHo) as a B-SNIP psychosis biomarker using traditional and machine learning approaches.

Ji L, Meda SA, Tamminga CA, Clementz BA, Keshavan MS, Sweeney JA, Gershon ES, Pearlson GD.

Schizophr Res. 2019 Aug 19. pii: S0920-9964(19)30293-2. doi: 10.1016/j.schres.2019.07.015. [Epub ahead of print]

PMID:
31439419
4.

Cell type-specific epigenetic links to schizophrenia risk in the brain.

Mendizabal I, Berto S, Usui N, Toriumi K, Chatterjee P, Douglas C, Huh I, Jeong H, Layman T, Tamminga CA, Preuss TM, Konopka G, Yi SV.

Genome Biol. 2019 Jul 9;20(1):135. doi: 10.1186/s13059-019-1747-7.

5.

Molecular alterations in the medial temporal lobe in schizophrenia.

Bobilev AM, Perez JM, Tamminga CA.

Schizophr Res. 2019 Jun 18. pii: S0920-9964(19)30222-1. doi: 10.1016/j.schres.2019.06.001. [Epub ahead of print]

PMID:
31227207
6.

Association of Choroid Plexus Enlargement With Cognitive, Inflammatory, and Structural Phenotypes Across the Psychosis Spectrum.

Lizano P, Lutz O, Ling G, Lee AM, Eum S, Bishop JR, Kelly S, Pasternak O, Clementz B, Pearlson G, Sweeney JA, Gershon E, Tamminga C, Keshavan M.

Am J Psychiatry. 2019 Jul 1;176(7):564-572. doi: 10.1176/appi.ajp.2019.18070825. Epub 2019 Jun 5.

PMID:
31164007
7.

Schizophrenia Exhibits Bi-directional Brain-Wide Alterations in Cortico-Striato-Cerebellar Circuits.

Ji JL, Diehl C, Schleifer C, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA, Hill SK, Pearlson G, Yang G, Creatura G, Krystal JH, Repovs G, Murray J, Winkler A, Anticevic A.

Cereb Cortex. 2019 Jun 3. pii: bhy306. doi: 10.1093/cercor/bhy306. [Epub ahead of print]

PMID:
31157363
8.

Auditory steady-state EEG response across the schizo-bipolar spectrum.

Parker DA, Hamm JP, McDowell JE, Keedy SK, Gershon ES, Ivleva EI, Pearlson GD, Keshavan MS, Tamminga CA, Sweeney JA, Clementz BA.

Schizophr Res. 2019 Jul;209:218-226. doi: 10.1016/j.schres.2019.04.014. Epub 2019 May 9.

PMID:
31080153
9.

Increased Protein Insolubility in Brains From a Subset of Patients With Schizophrenia.

Nucifora LG, MacDonald ML, Lee BJ, Peters ME, Norris AL, Orsburn BC, Yang K, Gleason K, Margolis RL, Pevsner J, Tamminga CA, Sweet RA, Ross CA, Sawa A, Nucifora FC Jr.

Am J Psychiatry. 2019 Sep 1;176(9):730-743. doi: 10.1176/appi.ajp.2019.18070864. Epub 2019 May 6.

PMID:
31055969
10.

Transdiagnostic dimensions of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP).

Reininghaus U, Böhnke JR, Chavez-Baldini U, Gibbons R, Ivleva E, Clementz BA, Pearlson GD, Keshavan MS, Sweeney JA, Tamminga CA.

World Psychiatry. 2019 Feb;18(1):67-76. doi: 10.1002/wps.20607.

11.

Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.

Rubin LH, Li S, Yao L, Keedy SK, Reilly JL, Hill SK, Bishop JR, Sue Carter C, Pournajafi-Nazarloo H, Drogos LL, Gershon E, Pearlson GD, Tamminga CA, Clementz BA, Keshavan MS, Lui S, Sweeney JA.

Schizophr Res. 2018 Dec;202:173-179. doi: 10.1016/j.schres.2018.07.003. Epub 2018 Jul 6.

PMID:
30539769
12.

VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.

Jiang C, Lin WJ, Labonté B, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR.

Neuropsychopharmacology. 2019 Apr;44(5):971-981. doi: 10.1038/s41386-018-0277-4. Epub 2018 Nov 20.

PMID:
30504797
13.

2018 in Review.

Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Glass O.

Am J Psychiatry. 2018 Dec 1;175(12):1163-1166. doi: 10.1176/appi.ajp.2018.18091065. No abstract available.

PMID:
30501415
14.

VEGFA GENE variation influences hallucinations and frontotemporal morphology in psychotic disorders: a B-SNIP study.

Lizano P, Lutz O, Ling G, Padmanabhan J, Tandon N, Sweeney J, Tamminga C, Pearlson G, Ruaño G, Kocherla M, Windemuth A, Clementz B, Gershon E, Keshavan M.

Transl Psychiatry. 2018 Oct 11;8(1):215. doi: 10.1038/s41398-018-0271-y.

15.

Using Brain-Based Phenotyping to Improve Discovery in Psychiatry.

Tamminga CA, Ivleva EI.

JAMA Psychiatry. 2018 Nov 1;75(11):1103-1104. doi: 10.1001/jamapsychiatry.2018.2451. No abstract available.

16.

Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders.

Lencer R, Yao L, Reilly JL, Keedy SK, McDowell JE, Keshavan MS, Pearlson GD, Tamminga CA, Gershon ES, Clementz BA, Lui S, Sweeney JA.

Hum Brain Mapp. 2019 Jan;40(1):163-174. doi: 10.1002/hbm.24362. Epub 2018 Sep 10.

PMID:
30260540
17.

New approaches in psychiatric drug development.

van der Doef TF, Zaragoza Domingo S, Jacobs GE, Drevets WC, Marston HM, Nathan PJ, Tome MB, Tamminga CA, van Gerven JMA, Kas MJH.

Eur Neuropsychopharmacol. 2018 Sep;28(9):983-993. doi: 10.1016/j.euroneuro.2018.06.006. Epub 2018 Jul 25. Review.

PMID:
30056086
18.

Reduced GluN1 in mouse dentate gyrus is associated with CA3 hyperactivity and psychosis-like behaviors.

Segev A, Yanagi M, Scott D, Southcott SA, Lister JM, Tan C, Li W, Birnbaum SG, Kourrich S, Tamminga CA.

Mol Psychiatry. 2018 Jul 23. doi: 10.1038/s41380-018-0124-3. [Epub ahead of print]

19.

Machine learning improved classification of psychoses using clinical and biological stratification: Update from the bipolar-schizophrenia network for intermediate phenotypes (B-SNIP).

Mothi SS, Sudarshan M, Tandon N, Tamminga C, Pearlson G, Sweeney J, Clementz B, Keshavan MS.

Schizophr Res. 2018 May 25. pii: S0920-9964(18)30250-0. doi: 10.1016/j.schres.2018.04.037. [Epub ahead of print] No abstract available.

PMID:
29807804
20.

Multivariate Relationships Between Cognition and Brain Anatomy Across the Psychosis Spectrum.

Rodrigue AL, McDowell JE, Tandon N, Keshavan MS, Tamminga CA, Pearlson GD, Sweeney JA, Gibbons RD, Clementz BA.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Dec;3(12):992-1002. doi: 10.1016/j.bpsc.2018.03.012. Epub 2018 Mar 31.

PMID:
29759822
21.

Can a Framework Be Established for the Safe Use of Ketamine?

Freedman R, Brown AS, Cannon TD, Druss BG, Earls FJ, Escobar J, Hurd YL, Lewis DA, López-Jaramillo C, Luby J, Mayberg HS, Moffitt TE, Oquendo M, Perlis RH, Pine DS, Rush AJ, Tamminga CA, Tohen M, Vieta E, Wisner KL, Xin Y.

Am J Psychiatry. 2018 Jul 1;175(7):587-589. doi: 10.1176/appi.ajp.2018.18030290. Epub 2018 Apr 16. No abstract available.

PMID:
29656666
22.

Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.

Shafee R, Nanda P, Padmanabhan JL, Tandon N, Alliey-Rodriguez N, Kalapurakkel S, Weiner DJ, Gur RE, Keefe RSE, Hill SK, Bishop JR, Clementz BA, Tamminga CA, Gershon ES, Pearlson GD, Keshavan MS, Sweeney JA, McCarroll SA, Robinson EB.

Transl Psychiatry. 2018 Apr 12;8(1):78. doi: 10.1038/s41398-018-0124-8.

23.

Welcome.

Tamminga CA, McMahon L.

Biol Psychiatry. 2018 May 1;83(9S):A10. doi: 10.1016/j.biopsych.2018.02.1170. Epub 2018 Mar 24. No abstract available.

PMID:
29636123
24.

Corrigendum: Sex-specific transcriptional signatures in human depression.

Labonté B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, Scarpa JR, Moy G, Loh YE, Cahill M, Lorsch ZS, Hamilton PJ, Calipari ES, Hodes GE, Issler O, Kronman H, Pfau M, Obradovic ALJ, Dong Y, Neve RL, Russo S, Kasarskis A, Tamminga C, Mechawar N, Turecki G, Zhang B, Shen L, Nestler EJ.

Nat Med. 2018 Apr 10;24(4):525. doi: 10.1038/nm0418-525d.

PMID:
29634684
25.

Associations between adolescent cannabis use and brain structure in psychosis.

Abush H, Ghose S, Van Enkevort EA, Clementz BA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA, Ivleva EI.

Psychiatry Res Neuroimaging. 2018 Jun 30;276:53-64. doi: 10.1016/j.pscychresns.2018.03.008. Epub 2018 Mar 28.

26.

Racial disparities in bipolar disorder treatment and research: a call to action.

Akinhanmi MO, Biernacka JM, Strakowski SM, McElroy SL, Balls Berry JE, Merikangas KR, Assari S, McInnis MG, Schulze TG, LeBoyer M, Tamminga C, Patten C, Frye MA.

Bipolar Disord. 2018 Sep;20(6):506-514. doi: 10.1111/bdi.12638. Epub 2018 Mar 12. Review.

27.

Autism BrainNet: A network of postmortem brain banks established to facilitate autism research.

Amaral DG, Anderson MP, Ansorge O, Chance S, Hare C, Hof PR, Miller M, Nagakura I, Pickett J, Schumann C, Tamminga C.

Handb Clin Neurol. 2018;150:31-39. doi: 10.1016/B978-0-444-63639-3.00003-7. Review.

PMID:
29496150
28.

Shared Genetic Risk of Schizophrenia and Gray Matter Reduction in 6p22.1.

Chen J, Calhoun VD, Lin D, Perrone-Bizzozero NI, Bustillo JR, Pearlson GD, Potkin SG, van Erp TGM, Macciardi F, Ehrlich S, Ho BC, Sponheim SR, Wang L, Stephen JM, Mayer AR, Hanlon FM, Jung RE, Clementz BA, Keshavan MS, Gershon ES, Sweeney JA, Tamminga CA, Andreassen OA, Agartz I, Westlye LT, Sui J, Du Y, Turner JA, Liu J.

Schizophr Bull. 2019 Jan 1;45(1):222-232. doi: 10.1093/schbul/sby010.

PMID:
29474680
29.

The association between mood state and chronobiological characteristics in bipolar I disorder: a naturalistic, variable cluster analysis-based study.

Gonzalez R, Suppes T, Zeitzer J, McClung C, Tamminga C, Tohen M, Forero A, Dwivedi A, Alvarado A.

Int J Bipolar Disord. 2018 Feb 19;6(1):5. doi: 10.1186/s40345-017-0113-5.

30.

Novel transcriptional networks regulated by CLOCK in human neurons.

Fontenot MR, Berto S, Liu Y, Werthmann G, Douglas C, Usui N, Gleason K, Tamminga CA, Takahashi JS, Konopka G.

Genes Dev. 2017 Nov 1;31(21):2121-2135. doi: 10.1101/gad.305813.117. Epub 2017 Dec 1.

31.

2017 in Review.

Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Katz R.

Am J Psychiatry. 2017 Dec 1;174(12):1140-1143. doi: 10.1176/appi.ajp.2017.17101073. No abstract available.

PMID:
29191032
32.

Social stress induces neurovascular pathology promoting depression.

Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, Janssen WG, Labonté B, Parise EM, Lorsch ZS, Golden SA, Heshmati M, Tamminga C, Turecki G, Campbell M, Fayad ZA, Tang CY, Merad M, Russo SJ.

Nat Neurosci. 2017 Dec;20(12):1752-1760. doi: 10.1038/s41593-017-0010-3. Epub 2017 Nov 13.

33.

VGF function in depression and antidepressant efficacy.

Jiang C, Lin WJ, Sadahiro M, Labonté B, Menard C, Pfau ML, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR.

Mol Psychiatry. 2018 Jul;23(7):1632-1642. doi: 10.1038/mp.2017.233. Epub 2017 Nov 21.

34.

Effects of genetic and environmental risk for schizophrenia on hippocampal activity and psychosis-like behavior in mice.

Scott D, Tamminga CA.

Behav Brain Res. 2018 Feb 26;339:114-123. doi: 10.1016/j.bbr.2017.10.039. Epub 2017 Nov 15.

35.

Genome-wide association studies of smooth pursuit and antisaccade eye movements in psychotic disorders: findings from the B-SNIP study.

Lencer R, Mills LJ, Alliey-Rodriguez N, Shafee R, Lee AM, Reilly JL, Sprenger A, McDowell JE, McCarroll SA, Keshavan MS, Pearlson GD, Tamminga CA, Clementz BA, Gershon ES, Sweeney JA, Bishop JR.

Transl Psychiatry. 2017 Oct 24;7(10):e1249. doi: 10.1038/tp.2017.210.

36.

Genetic analysis of deep phenotyping projects in common disorders.

Gershon ES, Pearlson G, Keshavan MS, Tamminga C, Clementz B, Buckley PF, Alliey-Rodriguez N, Liu C, Sweeney JA, Keedy S, Meda SA, Tandon N, Shafee R, Bishop JR, Ivleva EI.

Schizophr Res. 2018 May;195:51-57. doi: 10.1016/j.schres.2017.09.031. Epub 2017 Oct 20. Review.

37.

Psychosis subgroups differ in intrinsic neural activity but not task-specific processing.

Hudgens-Haney ME, Ethridge LE, McDowell JE, Keedy SK, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA.

Schizophr Res. 2018 May;195:222-230. doi: 10.1016/j.schres.2017.08.023. Epub 2017 Aug 24.

38.

Sex-specific transcriptional signatures in human depression.

Labonté B, Engmann O, Purushothaman I, Menard C, Wang J, Tan C, Scarpa JR, Moy G, Loh YE, Cahill M, Lorsch ZS, Hamilton PJ, Calipari ES, Hodes GE, Issler O, Kronman H, Pfau M, Obradovic ALJ, Dong Y, Neve RL, Russo S, Kazarskis A, Tamminga C, Mechawar N, Turecki G, Zhang B, Shen L, Nestler EJ.

Nat Med. 2017 Sep;23(9):1102-1111. doi: 10.1038/nm.4386. Epub 2017 Aug 21. Erratum in: Nat Med. 2018 Apr 10;24(4):525.

39.

Deviation from expected cognitive ability across psychotic disorders.

Hochberger WC, Combs T, Reilly JL, Bishop JR, Keefe RSE, Clementz BA, Keshavan MS, Pearlson GD, Tamminga CA, Hill SK, Sweeney JA.

Schizophr Res. 2018 Feb;192:300-307. doi: 10.1016/j.schres.2017.05.019. Epub 2017 May 22.

40.

Transdiagnostic Associations Between Functional Brain Network Integrity and Cognition.

Sheffield JM, Kandala S, Tamminga CA, Pearlson GD, Keshavan MS, Sweeney JA, Clementz BA, Lerman-Sinkoff DB, Hill SK, Barch DM.

JAMA Psychiatry. 2017 Jun 1;74(6):605-613. doi: 10.1001/jamapsychiatry.2017.0669.

41.

Intrinsic neural activity differences among psychotic illnesses.

Hudgens-Haney ME, Ethridge LE, Knight JB, McDowell JE, Keedy SK, Pearlson GD, Tamminga CA, Keshavan MS, Sweeney JA, Clementz BA.

Psychophysiology. 2017 Aug;54(8):1223-1238. doi: 10.1111/psyp.12875. Epub 2017 Apr 17.

42.

Cognitive burden of anticholinergic medications in psychotic disorders.

Eum S, Hill SK, Rubin LH, Carnahan RM, Reilly JL, Ivleva EI, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Gershon ES, Keshavan MS, Keefe RSE, Sweeney JA, Bishop JR.

Schizophr Res. 2017 Dec;190:129-135. doi: 10.1016/j.schres.2017.03.034. Epub 2017 Apr 6.

43.

Identifying dynamic functional connectivity biomarkers using GIG-ICA: Application to schizophrenia, schizoaffective disorder, and psychotic bipolar disorder.

Du Y, Pearlson GD, Lin D, Sui J, Chen J, Salman M, Tamminga CA, Ivleva EI, Sweeney JA, Keshavan MS, Clementz BA, Bustillo J, Calhoun VD.

Hum Brain Mapp. 2017 May;38(5):2683-2708. doi: 10.1002/hbm.23553. Epub 2017 Mar 10.

44.

Diverse Non-genetic, Allele-Specific Expression Effects Shape Genetic Architecture at the Cellular Level in the Mammalian Brain.

Huang WC, Ferris E, Cheng T, Hörndli CS, Gleason K, Tamminga C, Wagner JD, Boucher KM, Christian JL, Gregg C.

Neuron. 2017 Mar 8;93(5):1094-1109.e7. doi: 10.1016/j.neuron.2017.01.033. Epub 2017 Feb 23.

45.

Strategies for Advancing Disease Definition Using Biomarkers and Genetics: The Bipolar and Schizophrenia Network for Intermediate Phenotypes.

Tamminga CA, Pearlson GD, Stan AD, Gibbons RD, Padmanabhan J, Keshavan M, Clementz BA.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):20-27. doi: 10.1016/j.bpsc.2016.07.005. Epub 2016 Aug 2. Review.

PMID:
29560884
46.

2016 in Review.

Freedman R, Lewis DA, Michels R, Pine DS, Rush AJ, Schultz SK, Tamminga CA, Pier K.

Am J Psychiatry. 2016 Dec 1;173(12):1167-1170. No abstract available.

PMID:
27903107
47.

Endophenotypes, Epigenetics, Polygenicity and More: Irv Gottesman's Dynamic Legacy.

Braff DL, Tamminga CA.

Schizophr Bull. 2017 Jan;43(1):10-16. doi: 10.1093/schbul/sbw157. Epub 2016 Nov 21. Review.

48.

Sex differences in associations of arginine vasopressin and oxytocin with resting-state functional brain connectivity.

Rubin LH, Yao L, Keedy SK, Reilly JL, Bishop JR, Carter CS, Pournajafi-Nazarloo H, Drogos LL, Tamminga CA, Pearlson GD, Keshavan MS, Clementz BA, Hill SK, Liao W, Ji GJ, Lui S, Sweeney JA.

J Neurosci Res. 2017 Jan 2;95(1-2):576-586. doi: 10.1002/jnr.23820.

49.

Brain Structure Biomarkers in the Psychosis Biotypes: Findings From the Bipolar-Schizophrenia Network for Intermediate Phenotypes.

Ivleva EI, Clementz BA, Dutcher AM, Arnold SJM, Jeon-Slaughter H, Aslan S, Witte B, Poudyal G, Lu H, Meda SA, Pearlson GD, Sweeney JA, Keshavan MS, Tamminga CA.

Biol Psychiatry. 2017 Jul 1;82(1):26-39. doi: 10.1016/j.biopsych.2016.08.030. Epub 2016 Aug 31.

50.

Neural complexity as a potential translational biomarker for psychosis.

Hager B, Yang AC, Brady R, Meda S, Clementz B, Pearlson GD, Sweeney JA, Tamminga C, Keshavan M.

J Affect Disord. 2017 Jul;216:89-99. doi: 10.1016/j.jad.2016.10.016. Epub 2016 Oct 26.

Supplemental Content

Loading ...
Support Center